Wednesday, May 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

CounterACT Grants for Chemical Countermeasures Research

by Global Biodefense Staff
October 20, 2015
NIH CounterACT Chemical Countermeasure Program

The National Institutes of Health (NIH) CounterACT program fosters and supports research and development of new and improved therapeutics for chemical threats, including traditional chemical warfare agents, toxic industrial chemicals, and pesticides.

In Fiscal Year 2015, the following awards were made in the chemical defense medical countermeasures research area:

U01 Cooperative Research Awards

Blocking Arsenicals-induced Cutaneous Injury
Mohammad Athar, Ph.D. University of Alabama at Birmingham

Development of the Vitamin B12 Analog Cobinamide as a Hydrogen Sulfide Antidote
Gerry R. Boss, M.D. University of California San Diego

Bromine Inhalation Induced Lung Injury: Novel Mechanisms and Treatment Strategies
Sadis Matalon, Ph.D. University of Alabama at Birmingham

Molecular Imaging of Chemical Threats and Countermeasures
Charles M. Thompson, Ph.D. University of Montana Missoula

R21 Exploratory/Developmental Grants

Targeting the Glutamatergic System to Counteract Soman Toxicity in Immature Rats
Maria F.M. Braga, D.D.S., Ph.D. Uniformed Services University of the Health Sciences

Therapy for Ocular Mustard Gas Exposure Using Engineered FGF Derivatives
David D. Eveleth, Ph.D. E&B Technologies, LLC

Mechanisms and Countermeasures of Halogen-Induced Injury to Pregnant Mice
Sadis Matalon, Ph.D. University of Alabama at Birmingham

Amelioration of Soman-Induced Neuropathology with NAAG-related Compounds
Joseph T. McCabe, Ph.D. Uniformed Services University of the Health Sciences

Glutathione Monoesters to Counteract Ocular Chemical Injury
Vasilis Vasiliou, Ph.D. Yale University

Atropine for Chlorine Inhalation Toxicity
Livia A. Veress, M.D.
University of Colorado, Denver

CounterACT is part of the U.S. Health and Human (HHS) Services Public Health Emergency Medical Countermeasures Enterprise (PHEMCE), which coordinates medical countermeasure efforts across HHS and federal interagency partners. This NIH-led program includes a comprehensive network of Research Centers of Excellence, individual co-operative research projects, small business innovation research grants, contracts, and interagency agreements with the Department of Defense.

Tags: AntitoxinsAwards

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents
CBRNE

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

April 11, 2022
Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses
Pathogens

Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses

April 11, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC